Novel Patient Metastatic Pleural Effusion-Derived Xenograft Model of Renal Medullary Carcinoma Demonstrates Therapeutic Efficacy of Sunitinib

BACKGROUND: Renal medullary carcinoma (RMC) is a rare but aggressive tumor often complicated by early lung metastasis with few treatment options and very poor outcomes. There are currently no verified RMC patient-derived xenograft (PDX) mouse models established from metastatic pleural effusion (PE)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Alex Q., Ijiri, Masami, Rodriguez, Ryan, Gandour-Edwards, Regina, Lee, Joyce, Tepper, Clifford G., Li, Yueju, Beckett, Laurel, Lam, Kit, Goodwin, Neal, Satake, Noriko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032976/
https://www.ncbi.nlm.nih.gov/pubmed/33842362
http://dx.doi.org/10.3389/fonc.2021.648097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032976/
https://www.ncbi.nlm.nih.gov/pubmed/33842362
http://dx.doi.org/10.3389/fonc.2021.648097

Ejemplares similares